Long-term effects of 5,7-dihydroxytryptamine administered at birth on the development of brain monoamines.
D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D015306:Biogenic Monoamines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D004102:Dihydroxytryptamines / Q000494:pharmacology*; D005260:Female; D006321:Heart / Q000187:drug effects / Q000254:growth & development; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D014364:Tryptophan / Q000378:metabolism
D015306:Biogenic Monoamines; D004102:Dihydroxytryptamines; D015116:5,7-Dihydroxytryptamine; D006897:Hydroxyindoleacetic Acid; D014364:Tryptophan